Everjoy Health Group Co.,Ltd. (SHE:002162)
China · Delayed Price · Currency is CNY 3.910
+0.060 (1.56%)
Sep 16, 2026, 3:04 PM CST
Everjoy Health Group Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 3,596 | 4,286 | 3,184 | 3,975 | 4,188 | 4,429 | |
Market Cap Growth | -11.14% | 34.59% | -19.89% | -5.09% | -5.44% | 23.21% |
Enterprise Value | 3,971 | 4,622 | 3,519 | 4,293 | 4,656 | 4,892 |
Last Close Price | 3.91 | 4.66 | 3.46 | 4.29 | 4.52 | 4.78 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 349.46 | 637.10 | - | 79.39 | - | 95.92 |
Forward PE | - | 220.00 | 220.00 | 220.00 | 220.00 | 220.00 |
PS Ratio | 3.32 | 4.04 | 2.64 | 3.11 | 3.60 | 3.51 |
PB Ratio | 4.23 | 5.11 | 3.77 | 3.92 | 4.12 | 3.43 |
P/TBV Ratio | 4.52 | 5.32 | 4.01 | 4.22 | 4.43 | 3.85 |
P/FCF Ratio | 99.75 | 133.23 | 62.92 | 53.64 | - | 37.19 |
P/OCF Ratio | 52.98 | 57.88 | 38.72 | 32.15 | 161.84 | 28.90 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 3.67 | 4.35 | 2.92 | 3.36 | 4.01 | 3.88 |
EV/EBITDA Ratio | 45.36 | 91.64 | - | - | - | 39.30 |
EV/EBIT Ratio | 104.29 | 203.75 | - | - | - | 76.43 |
EV/FCF Ratio | 110.16 | 143.69 | 69.54 | 57.94 | - | 41.08 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.74 | 0.66 | 0.67 | 0.59 | 0.72 | 0.56 |
Debt / EBITDA Ratio | 7.17 | 7.25 | 105.78 | - | - | 5.21 |
Debt / FCF Ratio | 17.41 | 17.30 | 11.16 | 8.07 | - | 6.10 |
Net Debt / Equity Ratio | 0.41 | 0.43 | 0.39 | 0.25 | 0.39 | 0.29 |
Net Debt / EBITDA Ratio | 5.44 | 7.09 | -22.37 | -12.62 | -5.73 | 3.05 |
Net Debt / FCF Ratio | 9.78 | 11.12 | 6.54 | 3.39 | -28.95 | 3.19 |
Asset Turnover | 0.55 | 0.53 | 0.55 | 0.53 | 0.45 | 0.48 |
Inventory Turnover | 5.75 | 5.44 | 5.41 | 4.68 | 3.49 | 2.83 |
Quick Ratio | 0.63 | 0.52 | 0.61 | 0.76 | 0.72 | 0.74 |
Current Ratio | 1.01 | 0.90 | 0.86 | 1.05 | 0.99 | 1.10 |
Return on Equity (ROE) | 1.47% | 0.71% | -16.16% | 4.73% | -24.28% | 4.09% |
Return on Assets (ROA) | 1.20% | 0.71% | -1.50% | -1.67% | -3.00% | 1.53% |
Return on Invested Capital (ROIC) | 2.76% | 1.26% | -4.35% | -4.86% | -8.14% | 4.06% |
Return on Capital Employed (ROCE) | 2.90% | 1.70% | -4.10% | -4.30% | -8.10% | 3.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 0.29% | 0.16% | -4.62% | 1.26% | -6.64% | 1.04% |
FCF Yield | 1.00% | 0.75% | 1.59% | 1.86% | -0.33% | 2.69% |
Payout Ratio | 168.18% | 293.63% | - | 48.95% | - | 63.71% |
Buyback Yield / Dilution | 0.51% | 0.10% | 0.51% | -0.07% | -4.14% | -4.21% |